Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (... by Melissa Coffman, Emilie Guillot, Thomas Blondel, Catherine Garelli‐Paar, Shuo Feng, Susanne Heartsill, Clarke E. Atkins

Get full text

Efficacy of a mitral regurgitation severity index to predict long‐term outcome in dogs with myxomatous mitral valve disease by Michelle Vereb, Clarke E. Atkins, Darcy Adin, Thomas Blondel, Melissa Coffman, Seunggon Lee, Emilie Guillot, Jessica L. Ward

Get full text

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease by Marisa K. Ames, Shelly L. Vaden, Clarke E. Atkins, Jean‐Sebastien Palerme, Catherine E. Langston, Gregory F. Grauer, Sarah Shropshire, Christina Bove, Tracy Webb

Get full text

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs by Bruce W. Keene, Clarke E. Atkins, John D. Bonagura, Philip R. Fox, Jens Häggström, Virginia Luis Fuentes, Mark A. Oyama, John E. Rush, Rebecca Stepien, Masami Uechi

Get full text